Request Information
Contact Us

Impact Dashboard

Program performance across Florida.

SVR12 Cure Rate
0 %
Days til First Dose
0
Patient Navigation Support
0 /7
Referral Retention
0 %

SVR12 confirms sustained virologic response 12 weeks after treatment completion, the clinical standard for Hepatitis C cure.

Florida’s Hepatitis C Reality

A public health crisis concentrated within substance use treatment settings.

#2
National Rank for New HCV Infections
6.3
Cases per 100K (Florida)
1.5
U.S. Average per 100K
4×
Higher Than National Rate

Source: CDC Viral Hepatitis Surveillance Report, 2023.

Florida’s HCV Burden

Florida ranks #2 nationally for new Hepatitis C infections, with an acute rate four times the U.S. average.

The Treatment Gap in Florida SUD Facilities

Most programs educate. Fewer than one in five deliver curative treatment.

Total SUD Facilities
693
Offer HCV Education
449 (64.8%)
Offer HCV Testing
289 (41.7%)
Offer HCV Treatment
123 (17.7%)

Source: SAMHSA N-SUMHSS 2024 State Profiles.

Accelerated Access to Treatment

Reducing traditional barriers to Hepatitis C care.

National HCV Clearance
34%
U.S. viral clearance rate (2013–2022)
Lifeline SVR12
97%
Confirmed sustained virologic response 12 weeks post-treatment

Source: Wester et al., MMWR 2023; Lifeline Health internal performance data (2024–2025).

Closing the National HCV Care Gap

Performance compared to national Hepatitis C clearance rates.

28 Days
Average time from patient introduction to first dose of DAA therapy. Prior authorization, insurance navigation, and medication coordination managed by Lifeline Health.

Clinical Outcomes

Performance vs. national benchmarks

Overall Retention (2024–25)
96.91%
National RNA testing rate: 88%
SUD Referral Retention
94.25%
National viral clearance average: 34%

2025 Milestones

Notable achievements year-to-date

$6,043
Annual Cost — Untreated Chronic HCV
$47,711
Annual Cost — End Stage Liver Disease
$49.2B
Projected National Savings (10-Year)
On-Site
Telehealth Delivery
No Travel
Required for Patients
Minimal–Zero
Cost to Facility
Prior Auth
Managed by Lifeline

Data Sources: CDC Viral Hepatitis Surveillance Report (2023), SAMHSA TEDS 2023, N-SUMHSS 2024, Wester et al. 2023 MMWR, and Lifeline Health internal performance data (2023–2025).